Amicus Therapeutics, Inc. (FOLD)
14.33
+0.02
(+0.14%)
USD |
NASDAQ |
Feb 12, 16:00
14.34
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Free Cash Flow : 9.691M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BioMarin Pharmaceutical, Inc. | 825.79M |
| CorMedix, Inc. | 74.42M |
| Krystal Biotech, Inc. | 165.59M |
| MannKind Corp. | 42.74M |
| Keros Therapeutics, Inc. | 87.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 35.66M |
| Cash from Investing (Quarterly) | -1.299M |
| Cash from Financing (Quarterly) | -1.319M |
| Free Cash Flow Per Share (Quarterly) | 0.1136 |
| Free Cash Flow to Equity (Quarterly) | 35.77M |
| Free Cash Flow to Firm (Quarterly) | 41.19M |
| Free Cash Flow Yield | 0.22% |